The aim of the new study, led by three scientists, was to help turn green tea into an antiviral drug. The chemical compound epigallocatechin gallate (EGCG) has been found in green tea and has been of interest to experts for many years.
In recent years, due to the potent antiviral activity of EGCG against SARS-CoV-2 infection in in vitro models (ie outside of a living organism), it has become possible to use this chemical compound to treat people with coronavirus.
But EGCG is poorly absorbed in the intestines and heavily processed in the liver. Therefore, it can only be used as medicine with some restrictions. Scientists believe that EGCG can be added to throat and mouthwashes and some medications.
The results of the new study are published in the journal Phytomedicine Plus.
News cannot be equated with a doctor’s prescription. Consult an expert before making a decision.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
